Inactive Instrument

Stratec Biomedical AG Share Price Xetra

Equities

DE0007289001

Advanced Medical Equipment & Technology

End-of-day quote Xetra
- EUR - Intraday chart for Stratec Biomedical AG

Financials

Sales 2024 * 276M 295M 24.58B Sales 2025 * 297M 317M 26.45B Capitalization 506M 541M 45.15B
Net income 2024 * 19M 20.32M 1.69B Net income 2025 * 25M 26.73M 2.23B EV / Sales 2024 * 2.33 x
Net Debt 2024 * 137M 147M 12.22B Net Debt 2025 * 75.66M 80.89M 6.75B EV / Sales 2025 * 1.96 x
P/E ratio 2024 *
25.4 x
P/E ratio 2025 *
19.6 x
Employees -
Yield 2024 *
2.31%
Yield 2025 *
2.18%
Free-Float 59.43%
More Fundamentals * Assessed data

Latest transcript on Stratec Biomedical AG

Managers TitleAgeSince
Chief Executive Officer 56 01/98/01
Director of Finance/CFO 56 01/98/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 57 29/19/29
Chairman 66 20/22/20
Director/Board Member 70 21/20/21
More insiders
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
More about the company